Randomized controlled trial of probiotics for the prevention of spontaneous preterm delivery associated with intrauterine infection: study protocol.

PubWeight™: 0.76‹?›

🔗 View Article (PMC 2911410)

Published in Reprod Health on June 30, 2010

Authors

Leticia Krauss-Silva1, Maria Elizabeth L Moreira, Mariane B Alves, Maria R Rezende, Alcione Braga, Karla G Camacho, Maria Rosa R Batista, Clarisse Savastano, Antonio Almada-Horta, Fernando Guerra

Author Affiliations

1: Health Technology Assessment Unit, National School of Public Health, Oswaldo Cruz Foundation, Brazilian Health Ministry, Brazil, R, Leopoldo Bulhões, 1480, Rio de Janeiro, 21041-210, Brazil. leticiak@ensp.fiocruz.br.

Associated clinical trials:

Probiotics for the Prevention of Premature Birth and Neonatal Related Morbidity | NCT00303082

Articles cited by this

Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol (1991) 20.49

Metronidazole to prevent preterm delivery in pregnant women with asymptomatic bacterial vaginosis. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. N Engl J Med (2000) 5.15

The preterm prediction study: significance of vaginal infections. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Am J Obstet Gynecol (1995) 3.38

Reduced incidence of preterm delivery with metronidazole and erythromycin in women with bacterial vaginosis. N Engl J Med (1995) 3.34

The fetal inflammatory response syndrome. Am J Obstet Gynecol (1998) 3.22

A polymorphism in the promoter region of TNF and bacterial vaginosis: preliminary evidence of gene-environment interaction in the etiology of spontaneous preterm birth. Am J Obstet Gynecol (2004) 2.60

Amniotic fluid inflammatory cytokines (interleukin-6, interleukin-1beta, and tumor necrosis factor-alpha), neonatal brain white matter lesions, and cerebral palsy. Am J Obstet Gynecol (1997) 2.30

A fetal systemic inflammatory response is followed by the spontaneous onset of preterm parturition. Am J Obstet Gynecol (1998) 2.10

Validity of the vaginal gram stain for the diagnosis of bacterial vaginosis. Obstet Gynecol (1996) 2.07

Oral use of Lactobacillus rhamnosus GR-1 and L. fermentum RC-14 significantly alters vaginal flora: randomized, placebo-controlled trial in 64 healthy women. FEMS Immunol Med Microbiol (2003) 2.06

The scientific basis for probiotic strains of Lactobacillus. Appl Environ Microbiol (1999) 2.04

Definition of a type of abnormal vaginal flora that is distinct from bacterial vaginosis: aerobic vaginitis. BJOG (2002) 2.01

Interleukin-6 concentrations in umbilical cord plasma are elevated in neonates with white matter lesions associated with periventricular leukomalacia. Am J Obstet Gynecol (1996) 1.79

Infection and prematurity and the role of preventive strategies. Semin Neonatol (2002) 1.78

The relationship among inflammatory lesions of the umbilical cord (funisitis), umbilical cord plasma interleukin 6 concentration, amniotic fluid infection, and neonatal sepsis. Am J Obstet Gynecol (2000) 1.74

Oral probiotics can resolve urogenital infections. FEMS Immunol Med Microbiol (2001) 1.73

Use of microbial cultures and antibiotics in the prevention of infection-associated preterm birth. Am J Obstet Gynecol (2004) 1.72

A systemic fetal inflammatory response and the development of bronchopulmonary dysplasia. Am J Obstet Gynecol (1999) 1.67

Understanding the bacterial flora of the female genital tract. Clin Infect Dis (2001) 1.62

A disproportionate increase in IL-1beta over IL-1ra in the cervicovaginal secretions of pregnant women with altered vaginal microflora correlates with preterm birth. Am J Obstet Gynecol (2004) 1.60

Risk factors for preterm birth subtypes. Epidemiology (1998) 1.55

Characterisation and selection of a Lactobacillus species to re-colonise the vagina of women with recurrent bacterial vaginosis. J Med Microbiol (2000) 1.53

Probiotic Lactobacillus dose required to restore and maintain a normal vaginal flora. FEMS Immunol Med Microbiol (2001) 1.52

The preterm prediction study: a clinical risk assessment system. Am J Obstet Gynecol (1996) 1.51

Vaginal indicators of amniotic fluid infection in preterm labor. Obstet Gynecol (2001) 1.50

Interrelationships of interleukin-8 with interleukin-1beta and neutrophils in vaginal fluid of healthy and bacterial vaginosis positive women. Mol Hum Reprod (2003) 1.48

Probiotics for mother and child. J Clin Gastroenterol (2004) 1.44

Ingestion of probiotics: optional treatment of bacterial vaginosis in pregnancy. Isr Med Assoc J (2002) 1.42

Probiotics during pregnancy and breast-feeding might confer immunomodulatory protection against atopic disease in the infant. J Allergy Clin Immunol (2002) 1.36

Cervicovaginal microflora and pregnancy outcome: results of a double-blind, placebo-controlled trial of erythromycin treatment. Am J Obstet Gynecol (1990) 1.30

Choriodecidual infection and preterm birth. Nutr Rev (2002) 1.26

Randomized clinical trial of metronidazole plus erythromycin to prevent spontaneous preterm delivery in fetal fibronectin-positive women. Obstet Gynecol (2003) 1.17

Bacterial vaginosis, the inflammatory response and the risk of preterm birth: a role for genetic epidemiology in the prevention of preterm birth. Am J Obstet Gynecol (2004) 1.13

Lactic acid bacteria inhibit TH2 cytokine production by mononuclear cells from allergic patients. J Allergy Clin Immunol (2002) 1.12

Elevated interleukin-8 concentrations in amniotic fluid of mothers whose neonates subsequently develop bronchopulmonary dysplasia. Eur J Obstet Gynecol Reprod Biol (1998) 1.11

Microbial-gut interactions in health and disease. Probiotics. Best Pract Res Clin Gastroenterol (2004) 1.10

Immunoglobulin A response against Gardnerella vaginalis hemolysin and sialidase activity in bacterial vaginosis. Am J Obstet Gynecol (1998) 1.10

Interleukins-1, -4, -6, -10, tumor necrosis factor, transforming growth factor-beta, FAS, and mannose-binding protein C gene polymorphisms in Australian women: Risk of preterm birth. Am J Obstet Gynecol (2004) 1.09

Interleukin-6 promoter -174 polymorphism and spontaneous preterm birth. Am J Obstet Gynecol (2003) 1.08

Decreased cervical proinflammatory cytokines permit subsequent upper genital tract infection during pregnancy. Am J Obstet Gynecol (2003) 1.08

The preterm prediction study: can low-risk women destined for spontaneous preterm birth be identified? Am J Obstet Gynecol (2001) 1.07

Impairment of the mucosal immune system: IgA and IgM cleavage detected in vaginal washings of a subgroup of patients with bacterial vaginosis. J Infect Dis (1998) 1.01

Time course of the regression of asymptomatic bacterial vaginosis in pregnancy with and without treatment. Am J Obstet Gynecol (2004) 0.99

[Factors associated with perinatal morbidity and mortality in a sample of public and private maternity centers in the City of Rio de Janeiro, 1999-2001]. Cad Saude Publica (2004) 0.99

The potential for probiotics to prevent bacterial vaginosis and preterm labor. Am J Obstet Gynecol (2003) 0.98

Differences in the fetal interleukin-6 response to microbial invasion of the amniotic cavity between term and preterm gestation. J Matern Fetal Neonatal Med (2003) 0.98

Early pregnancy threshold vaginal pH and Gram stain scores predictive of subsequent preterm birth in asymptomatic women. Am J Obstet Gynecol (2003) 0.97

Elevated vaginal pH and neutrophils are associated strongly with early spontaneous preterm birth. Am J Obstet Gynecol (2003) 0.97

Selection of lactobacillus strains for urogenital probiotic applications. J Infect Dis (2001) 0.96

Tumor necrosis factor-alpha promoter gene polymorphism -308 and chorioamnionitis. Obstet Gynecol (2003) 0.95

What we have learned about the predictors of preterm birth. Semin Perinatol (2003) 0.92

Vaginal Immunity in Bacterial Vaginosis. Curr Infect Dis Rep (2004) 0.92

Vaginal hydrolytic enzymes, immunoglobulin A against Gardnerella vaginalis toxin, and risk of early preterm birth among women in preterm labor with bacterial vaginosis or intermediate flora. Am J Obstet Gynecol (2002) 0.90

Probiotics and non-intestinal infectious conditions. Br J Nutr (2002) 0.88

Specific immune response against Gardnerella vaginalis hemolysin in patients with bacterial vaginosis. Am J Obstet Gynecol (1996) 0.84

[Consistency between data sources and inter-observer reliability in the Study on Neonatal and Perinatal Morbidity and Mortality and Care in the City of Rio de Janeiro]. Cad Saude Publica (2004) 0.83

Combination of vaginal pH with vaginal sialidase and prolidase activities for prediction of low birth weight and preterm birth. Am J Obstet Gynecol (2005) 0.83

Cervical fluid cytokines in pregnant women: Relation to vaginal wet mount findings and polymorphonuclear leukocyte counts. Eur J Obstet Gynecol Reprod Biol (2008) 0.82

Microecology, bacterial vaginosis and probiotics: perspectives for bacteriotherapy. Med Hypotheses (2001) 0.82

Articles by these authors

Household transmission of pandemic (H1N1) 2009, San Antonio, Texas, USA, April-May 2009. Emerg Infect Dis (2010) 1.64

What is predictive of preterm delivery in the first trimester: isthmus or cervical length? Prenat Diagn (2013) 1.38

Physicochemical characterization of biomaterials commonly used in dentistry as bone substitutes--comparison with human bone. J Biomed Mater Res B Appl Biomater (2010) 1.17

Chronic disease and disasters medication demands of Hurricane Katrina evacuees. Am J Prev Med (2007) 1.03

Immunogenicity and safety of an inactivated hepatitis A vaccine administered concomitantly with diphtheria-tetanus-acellular pertussis and haemophilus influenzae type B vaccines to children less than 2 years of age. Pediatrics (2006) 0.98

Aflatoxin and PAH exposure biomarkers in a U.S. population with a high incidence of hepatocellular carcinoma. Sci Total Environ (2010) 0.92

Platform switch versus platform match in the posterior mandible – 1-year results of a multicentre randomized clinical trial. J Clin Periodontol (2014) 0.88

Immediate and early loading of Straumann implants with a chemically modified surface (SLActive) in the posterior mandible and maxilla: 1-year results from a prospective multicenter study. Clin Oral Implants Res (2008) 0.86

Immunogenicity, safety and reactogenicity of a mammalian cell-culture-derived influenza vaccine in healthy children and adolescents three to seventeen years of age. Pediatr Infect Dis J (2012) 0.85

Acute hepatitis associated with autochthonous hepatitis E virus infection--San Antonio, Texas, 2009. Clin Infect Dis (2011) 0.83

Immediate and early non-occlusal loading of Straumann implants with a chemically modified surface (SLActive) in the posterior mandible and maxilla: interim results from a prospective multicenter randomized-controlled study. Clin Oral Implants Res (2008) 0.82

Basic vaginal pH, bacterial vaginosis and aerobic vaginitis: prevalence in early pregnancy and risk of spontaneous preterm delivery, a prospective study in a low socioeconomic and multiethnic South American population. BMC Pregnancy Childbirth (2014) 0.79

A randomised controlled trial of probiotics for the prevention of spontaneous preterm delivery associated with bacterial vaginosis: preliminary results. Trials (2011) 0.79

Immediate and early loading of chemically modified implants in posterior jaws: 3-year results from a prospective randomized multicenter study. Clin Implant Dent Relat Res (2011) 0.78

Ensuring preparedness for potential poliomyelitis outbreaks: Recommendations for the US poliovirus vaccine stockpile from the National Vaccine Advisory Committee (NVAC) and the Advisory Committee on Immunization Practices (ACIP). Arch Pediatr Adolesc Med (2004) 0.78

Clinical and histological evaluation of an acellular dermal matrix allograft in combination with the coronally advanced flap in the treatment of Miller class I recession defects: an experimental study in the mini-pig. J Clin Periodontol (2009) 0.77

Evaluation of an anorganic bovine-derived mineral with P-15 hydrogel bone graft: preliminary study in a rabbit cranial bone model. Clin Oral Implants Res (2011) 0.77

Comparison of a xenogeneic and an alloplastic material used in dental implants in terms of physico-chemical characteristics and in vivo inflammatory response. Mater Sci Eng C Mater Biol Appl (2013) 0.76

Urothelial cells in smears from cervix uteri. J Cytol (2012) 0.75

Reassessing the value of cardiofemoral index in the management of Rh(D) alloimmunized pregnancies: a pilot study. Eur J Obstet Gynecol Reprod Biol (2011) 0.75

Evaluation of the Utility of in utero Treatment of Twin Anemia-Polycythemia Sequence. Fetal Diagn Ther (2015) 0.75

Session 2 introduction: health systems in the United kingdom and the United States and their role in increasing equity. Pediatrics (2003) 0.75

Vascular pattern in monochorionic placentas with spontaneous TAPS and TTTS with residual anastomoses after laser: a case-control study. Prenat Diagn (2013) 0.75

Total body water in small- and appropriate- for gestational age newborns. J Perinat Med (2008) 0.75

Evaluation of prenatal and postnatal diagnostic criteria for twin anemia-polycythemia sequence. Prenat Diagn (2015) 0.75

Experimental fetal endoscopic tracheal occlusion in rhesus and cynomolgus monkeys: nonhuman primate models. J Matern Fetal Neonatal Med (2014) 0.75

Description of the male of <i>Phoebe</i> <i>ornator</i> (Tippmann, 1960) (Coleoptera: Cerambycidae: Lamiinae: Hemilophini), analysis of the species biogeography, and first observation of chromatic gender dimorphism in Hemilophini. Zootaxa (2017) 0.75

Predictive value of cardiovascular parameters in stages 1 and 2 of twin-to-twin transfusion syndrome. Prenat Diagn (2014) 0.75